Abstract:Objective: Accumulating evidence suggests that activation of mouse constitutive androstane receptor (mCAR) alleviates type 2 diabetes and obesity by inhibiting hepatic gluconeogenesis, lipogenesis, and fatty acid synthesis. However, the role of human (h) CAR in energy metabolism is largely unknown. The present study aims to investigate the effects of selective hCAR activators on hepatic energy metabolism in human primary hepatocytes (HPH).Methods: Ligand-based structure activity models were used for virtual screening of the Specs database (www.specs.net) followed by biological validation in cell-based luciferase assays. The effects of two novel hCAR activators (UM104 and UM145) on hepatic energy metabolism were evaluated in HPH.Results: Real-time PCR and Western blotting analyses reveal that activation of hCAR by UM104 and UM145 significantly repressed the expression of glucose-6-phosphatase and phosphoenolpyruvate carboxykinase, two pivotal gluconeogenic enzymes, while exerting negligible effects on the expression of genes associated with lipogenesis and fatty acid synthesis. Functional experiments show that UM104 and UM145 markedly inhibit hepatic synthesis of glucose but not triglycerides in HPH. In contrast, activation of mCAR by 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene, a selective mCAR activator, repressed the expression of genes associated with gluconeogenesis, lipogenesis, and fatty acid synthesis in mouse primary hepatocytes, which were consistent with previous observations in mouse model in vivo.Conclusion: Our findings uncover an important species difference between hCAR and mCAR in hepatic energy metabolism, where hCAR selectively inhibits gluconeogenesis without suppressing fatty acid synthesis. Implications: Such species selectivity should be considered when exploring CAR as a potential therapeutic target for metabolic disorders. (C) 2014 Elsevier Inc. All rights reserved.

The Constitutive Androstane Receptor is an Anti-Obesity Nuclear Receptor That Improves Insulin Sensitivity

Gadd45b is Required in Part for the Anti-Obesity Effect of Constitutive Androstane Receptor (CAR)

Anhydroicaritin Improves Diet-Induced Obesity and Hyperlipidemia and Alleviates Insulin Resistance by Suppressing SREBPs Activation

Ganoderic Acid A improves high fat diet-induced obesity, lipid accumulation and insulin sensitivity through regulating SREBP pathway

Db121039 1876..1887

Constitutive Androstane Receptor Activation Decreases Plasma Apolipoprotein B–Containing Lipoproteins and Atherosclerosis in Low-Density Lipoprotein Receptor–Deficient Mice

Activation of the Constitutive Androstane Receptor Inhibits Gluconeogenesis Without Affecting Lipogenesis or Fatty Acid Synthesis in Human Hepatocytes

The CAR Agonist TCPOBOP Inhibits Lipogenesis and Promotes Fibrosis in the Mammary Gland of Adolescent Female Mice

Clinical Relevance of the Constitutive Androstane Receptor.

Pxr Ablation Alleviates Diet-Induced and Genetic Obesity and Insulin Resistance in Mice

Constitutive Androstane Receptor is Upregulated During Porcine Primary Preadipocyte Differentiation

Activation of the Constitutive Androstane Receptor induces hepatic lipogenesis and regulates Pnpla3 gene expression in a LXR-independent way

Gestational Diabetes Sensitizes Mice to Future Metabolic Syndrome That Can Be Relieved by Activating CAR

Identification of Novel Activators of Constitutive Androstane Receptor from FDA-Approved Drugs by Integrated Computational and Biological Approaches

Activation of the Constitutive Androstane Receptor Decreases Hdl in Wild-Type and Human Apoa-I Transgenic Mice

Genome-wide analysis of human constitutive androstane receptor (CAR) transcriptome in wild-type and CAR-knockout HepaRG cells

High-content Analysis of Constitutive Androstane Receptor (CAR) Translocation Identifies Mosapride Citrate As a CAR Agonist That Represses Gluconeogenesis

The Full Capacity of Aicar to Reduce Obesity-Induced Inflammation and Insulin Resistance Requires Myeloid Sirt1

Signaling Control of the Constitutive Androstane Receptor （CAR）

A Functional Cross-Talk Between Liver X Receptor-Alpha And Constitutive Androstane Receptor Links Lipogenesis And Xenobiotic Responses

Molecular Basis of Metabolism-Mediated Conversion of PK11195 from an Antagonist to an Agonist of the Constitutive Androstane Receptor.